SELLAS LIFE SCIENCES GROUP, INC.

Analyst Reco. SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.46 ^USD	-3.95%		-5.19%	+37.74%

Apr. 03	North American Morning Briefing : Powell Awaited -2-	DJ
Mar. 28	SELLAS Life Sciences Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences Group to $6 From $10, Keeps Overweight Rating	22-06-28	MT
Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to $14 From $16.50, Reiterates Buy Rating	22-04-08	MT
Ladenburg Thalmann Starts SELLAS Life Sciences Group at Buy with $15 Price Target	22-02-07	MT
Maxim Group Adjusts SELLAS Life Sciences Group Price Target to $12 From $21, Maintains Buy Rating	22-02-02	MT
Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences to $16 From $18, Reiterates Overweight Rating	21-12-03	MT
SELLAS LIFE SCIENCES : Cantor Fitzgerald Starts SELLAS Life Sciences Group at Overweight With $18 Price Target	21-07-21	MT
SELLAS LIFE SCIENCES : Maxim Adjusts Price Target on SELLAS Life Sciences Group to $21 From $12, Keeps Buy Rating	21-06-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer